Comparison of registered and published primary outcomes in randomized controlled trials of gastroenterology and hepatology
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
OBJECTIVES. The need for trial registration as well as the benefits it has brought for the transparency of medical research has been recognized for years. Trial registration has turned from an exception to a mandatory guideline in recent years. The present study aimed to examine the characteristics of registered randomized controlled trials (RCTs) in a sample of recently published gastroenterology RCTs, and to assess the consistency of registered and published primary outcome (PO) in RCTs. METHODS. Articles published in the top five "general and internal journals" and top five "gastroenterology and hepatology journals" categories between 2009 and 2012 were searched in PubMed. Basic characteristics and the registration information were identified and extracted from the included RCTs. PO consistency analysis was conducted to compare between the registered and published format. RESULTS. A total of 305 RCTs were included; among them 252 could be identified with a registration number. Nearly half of these RCTs were funded solely by industry (141/305, 46.3%). ClinicalTrials.gov was the most popular registry for these RCTs (214/252, 84.9%). A total of 155 RCTs were included in the PO consistency analysis. Among them, 22 (14.2%) RCTs had discrepancies between POs registered in the trial registry compared to the published article. CONCLUSIONS. Based on the results of the present study, selective outcome reporting of gastroenterology RCTs published in leading medical journals has been much improved over the past years. However, there might be a sampling bias to say that consistency of registered and published POs of gastroenterology RCTs has been better than before.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“Several factors contributed to the change of PO; however, authors seldom mentioned the reasons in their report and it left the general public to suspect that their motivation was related to the benefit of their sponsors, especially those for-profit pharmaceutical companies [27,28].”
BackgroundChan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845 · cited 2×
“It is common that some prespecified outcome measures omitted or changed in the published paper due to various factors [25].”
BackgroundThe ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838
Als-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746 · cited 1×
“These studies are usually well designed, have a larger sample size (phase III or phase IV trials), and were conducted in multiple centers [32,33], which favored published in medical journals; however, it is quite hard to tell how many negative results and adverse events were hidden from publication [34–36].”
BackgroundComparison of Registered and Published Primary Outcomes in Randomized Controlled Trials
Mathieu, S. (2009) · JAMA · doi:10.1001/jama.2009.1242 · Cited by 730
Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010
Califf, R. M. (2012) · JAMA · doi:10.1001/jama.2012.3424 · Cited by 516
Dickersin, K. (2003) · JAMA · doi:10.1001/jama.290.4.516 · Cited by 512
Publication Bias in Editorial Decision Making
Olson, C. M. (2002) · JAMA · doi:10.1001/jama.287.21.2825 · Cited by 395 · cited 1×
“First, authors may selectively report statistically significant outcomes as studies with positive results are more likely to be published than studies with negative results (publication bias) [29].”
ResultOutcome Reporting Among Drug Trials Registered in ClinicalTrials.gov
Bourgeois, F. T., Murthy, S., & Mandl, K. D. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00006 · Cited by 332
Bero, L., Oostvogel, F., Bacchetti, P., & Lee, K. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040184 · Cited by 249 · cited 1×
“Several factors contributed to the change of PO; however, authors seldom mentioned the reasons in their report and it left the general public to suspect that their motivation was related to the benefit of their sponsors, especially those for-profit pharmaceutical companies [27,28].”
Background
Cited by
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Comparison of registered and published outcomes in randomized controlled trials: a systematic review
Jones, C. W., Keil, L. G., Holland, W. C., Caughey, M. C., & Platts-Mills, T. F. (2015) · BMC Medicine · doi:10.1186/s12916-015-0520-3 · Cited by 237
“, 2013 [27] 155 7 (5) 5 (3) 9 (6) 6 (4) 6 (4)”
BackgroundResultInfluentialChen, T., Li, C., Qin, R., Wang, Y., Yu, D., Dodd, J., Wang, D., & Cornelius, V. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.7242 · Cited by 68
Bashir, R., Bourgeois, F. T., & Dunn, A. G. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0518-3 · Cited by 47
TARG Meta-Research Group & Collaborators (2023) · BMJ Open · doi:10.1136/bmjopen-2023-076264 · Cited by 33
Metadata
- Authors
- Li, X.-Q., Yang, G.-L., Tao, K.-M., Zhang, H.-Q., Zhou, Q.-H., & Ling, C.-Q.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 2013-10-16
- Volume
- 48
- Issue
- 12
- Pages
- 1474-1483
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W2066898878
- Cited by
- 25
- References
- 15
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of registered and published primary outcomes in randomized controlled trials of gastroenterology and hepatology. https://app.cochat.ai/papers/10.3109/00365521.2013.845909
- The paper
- Li, X.-Q., Yang, G.-L., Tao, K.-M., Zhang, H.-Q., Zhou, Q.-H., & Ling, C.-Q. (2013). Comparison of registered and published primary outcomes in randomized controlled trials of gastroenterology and hepatology. Scandinavian Journal of Gastroenterology. https://doi.org/10.3109/00365521.2013.845909
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.